十一月 2025
- Home
- Acorda Therapeutics, Inc.
十一月 2025的Acorda Therapeutics, Inc.市场份额分析
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders.
Acorda Therapeutics, Inc.(包含公司地区分支机构)
查看更多网站流量和参与度信息- acorda.com
Acorda Therapeutics, Inc.收入截至 十一月 2025为 100M - 200M
Acorda Therapeutics, Inc.主要域名产生的收入
3 年中Acorda Therapeutics, Inc.主要域名的收入
Acorda Therapeutics, Inc.主要域名的收入
Acorda Therapeutics, Inc.热门域名的总访问量
了解Acorda Therapeutics, Inc.市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Acorda Therapeutics, Inc.热门域名的平均访问时长
分析Acorda Therapeutics, Inc.参与度指标。
过去 3 个月的平均访问时长
子公司明细
Acorda Therapeutics, Inc.热门域名的平均页面浏览量
了解Acorda Therapeutics, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Acorda Therapeutics, Inc. 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Acorda decreased headcount by 97 on Jun 1st '24.PEARL RIVER - Acorda Therapeutics, which manufactures key medications used by MS and Parkinson's patients, will lay off all its 97 employees in June, according to a notice filed with the New York State Department of Labor.
四月 8, 2024阅读更多
新闻Acorda decreases headcount by 120.A couple weeks after the high court refused to take the case, Acorda announced plans to lay off a quarter of its workforce, or about 120 employees, as part of a larger restructuring designed to cut costs.
四月 1, 2024阅读更多
新闻Acorda sells assets to Merz Group.Merz Therapeutics, a business of Frankfurt-based Merz Group, has entered into an Asset Purchase Agreement to acquire two commercial medicines from NASDAQ-listed Acorda Therapeutics.
四月 1, 2024阅读更多
查看 Acorda Therapeutics, Inc. 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。